EdgarLookup

CHS INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CHS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
1.7%
Profit Margin
Net income ÷ revenue
3.2%
Return on Assets
Net income ÷ assets
-9.7%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $35.46B Nov 5, 2025
FY2025 Aug 31, 2024 $39.26B Nov 5, 2025
FY2025 Aug 31, 2023 $45.59B Nov 5, 2025
FY2024 Aug 31, 2022 $47.79B Nov 6, 2024
FY2023 Aug 31, 2021 $38.45B Nov 8, 2023
FY2022 Aug 31, 2020 $28.41B Nov 2, 2022
FY2021 Aug 31, 2019 $31.90B Nov 4, 2021
FY2018 Aug 31, 2018 $8.58B Dec 3, 2018
FY2018 May 31, 2018 $9.09B Dec 3, 2018
FY2018 Feb 28, 2018 $6.98B Dec 3, 2018

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $35.46B Nov 5, 2025
FY2025 Aug 31, 2024 $39.26B Nov 5, 2025
FY2025 Aug 31, 2023 $45.59B Nov 5, 2025
FY2024 Aug 31, 2022 $47.79B Nov 6, 2024
FY2023 Aug 31, 2021 $38.45B Nov 8, 2023
FY2022 Aug 31, 2020 $28.41B Nov 2, 2022
FY2021 Aug 31, 2019 $31.90B Nov 4, 2021

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Aug 31, 2017 $31.94M Nov 9, 2017
FY2017 Aug 31, 2016 $30.35M Nov 9, 2017
FY2017 Aug 31, 2015 $34.58M Nov 9, 2017
FY2016 Aug 31, 2014 $42.66M Nov 3, 2016
FY2015 Aug 31, 2013 $44.48M Nov 23, 2015

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $1.14B Nov 5, 2025
FY2025 Aug 31, 2024 $1.75B Nov 5, 2025
FY2025 Aug 31, 2023 $2.38B Nov 5, 2025
FY2024 Aug 31, 2022 $2.13B Nov 6, 2024
FY2023 Aug 31, 2021 $951.40M Nov 8, 2023
FY2022 Aug 31, 2020 $981.81M Nov 2, 2022
FY2021 Aug 31, 2019 $1.38B Nov 4, 2021
FY2018 Aug 31, 2018 $391.36M Dec 3, 2018
FY2018 May 31, 2018 $245.97M Dec 3, 2018
FY2018 Feb 28, 2018 $135.30M Dec 3, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $597.92M Nov 5, 2025
FY2025 Aug 31, 2024 $1.10B Nov 5, 2025
FY2025 Aug 31, 2023 $1.90B Nov 5, 2025
FY2024 Aug 31, 2022 $1.68B Nov 6, 2024
FY2023 Aug 31, 2021 $553.95M Nov 8, 2023
FY2022 Aug 31, 2020 $422.44M Nov 2, 2022
FY2021 Aug 31, 2019 $829.88M Nov 4, 2021
FY2018 Aug 31, 2018 $240.45M Dec 3, 2018
FY2018 May 31, 2018 $181.81M Dec 3, 2018
FY2018 Feb 28, 2018 $166.01M Dec 3, 2018

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $90.76M Nov 5, 2025
FY2025 Aug 31, 2024 $584.36M Nov 5, 2025
FY2025 Aug 31, 2023 $1.34B Nov 5, 2025
FY2024 Aug 31, 2022 $1.13B Nov 6, 2024
FY2023 Aug 31, 2021 $205.80M Nov 8, 2023
FY2022 Aug 31, 2020 $277.27M Nov 2, 2022
FY2021 Aug 31, 2019 $659.60M Nov 4, 2021
FY2018 Aug 31, 2018 $223.84M Dec 3, 2018
FY2018 May 31, 2018 $88.20M Dec 3, 2018
FY2018 Feb 28, 2018 ($40.06M) Dec 3, 2018

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $1.05B Nov 5, 2025
FY2025 Aug 31, 2024 $1.17B Nov 5, 2025
FY2025 Aug 31, 2023 $1.03B Nov 5, 2025
FY2024 Aug 31, 2022 $997.84M Nov 6, 2024
FY2023 Aug 31, 2021 $745.60M Nov 8, 2023
FY2022 Aug 31, 2020 $704.54M Nov 2, 2022
FY2021 Aug 31, 2019 $724.73M Nov 4, 2021
FY2018 Aug 31, 2018 $186.29M Dec 3, 2018
FY2018 May 31, 2018 $161.58M Dec 3, 2018
FY2018 Feb 28, 2018 $186.71M Dec 3, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $635.79M Nov 5, 2025
FY2025 Aug 31, 2024 $1.27B Nov 5, 2025
FY2025 Aug 31, 2023 $3.28B Nov 5, 2025
FY2024 Aug 31, 2022 $1.95B Nov 6, 2024
FY2023 Aug 31, 2021 $757.81M Nov 8, 2023
FY2022 Aug 31, 2020 $1.09B Nov 2, 2022
FY2021 Aug 31, 2019 $1.14B Nov 4, 2021
FY2020 Aug 31, 2018 $1.07B Nov 5, 2020
FY2019 Aug 31, 2017 $954.70M Nov 6, 2019
FY2018 Aug 31, 2016 $1.26B Dec 3, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $728.58M Nov 5, 2025
FY2025 Aug 31, 2024 $808.76M Nov 5, 2025
FY2025 Aug 31, 2023 $564.52M Nov 5, 2025
FY2024 Aug 31, 2022 $354.44M Nov 6, 2024
FY2023 Aug 31, 2021 $317.79M Nov 8, 2023
FY2022 Aug 31, 2020 $418.36M Nov 2, 2022
FY2021 Aug 31, 2019 $443.22M Nov 4, 2021
FY2020 Aug 31, 2018 $355.41M Nov 5, 2020
FY2019 Aug 31, 2017 $444.40M Nov 6, 2019
FY2018 Aug 31, 2016 $692.78M Dec 3, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $18.86B Nov 5, 2025
FY2025 Aug 31, 2024 $18.72B Nov 5, 2025
FY2024 Aug 31, 2023 $18.96B Nov 6, 2024
FY2023 Aug 31, 2022 $18.82B Nov 8, 2023
FY2022 Aug 31, 2021 $17.58B Nov 2, 2022
FY2021 Aug 31, 2020 $15.99B Nov 4, 2021
FY2020 Aug 31, 2019 $16.45B Nov 5, 2020
FY2019 Aug 31, 2018 $16.38B Nov 6, 2019
FY2018 May 31, 2018 $16.70B Dec 3, 2018
FY2018 Feb 28, 2018 $17.00B Dec 3, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $11.08B Nov 5, 2025
FY2025 Aug 31, 2024 $10.76B Nov 5, 2025
FY2024 Aug 31, 2023 $10.45B Nov 6, 2024
FY2023 Aug 31, 2022 $9.46B Nov 8, 2023
FY2022 Aug 31, 2021 $9.01B Nov 2, 2022
FY2021 Aug 31, 2020 $8.81B Nov 4, 2021
FY2020 Aug 31, 2019 $8.61B Nov 5, 2020
FY2019 Aug 31, 2018 $8.16B Nov 6, 2019
FY2018 May 31, 2018 $7.91B Dec 3, 2018
FY2018 Feb 28, 2018 $7.85B Dec 3, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $239.44M Nov 5, 2025
FY2025 Aug 31, 2024 $179.98M Nov 5, 2025
FY2024 Aug 31, 2023 $179.98M Nov 6, 2024
FY2023 Aug 31, 2022 $179.98M Nov 8, 2023
FY2023 Aug 31, 2021 $171.60M Nov 8, 2023
FY2022 Aug 31, 2020 $172.40M Nov 2, 2022
FY2020 Aug 31, 2019 $172.40M Nov 5, 2020
FY2019 Aug 31, 2018 $138.46M Nov 6, 2019
FY2019 Aug 31, 2017 $138.45M Nov 6, 2019
FY2018 Aug 31, 2016 $144.28M Dec 3, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $3.02B Nov 5, 2025
FY2025 Aug 31, 2024 $2.81B Nov 5, 2025
FY2024 Aug 31, 2023 $2.54B Nov 6, 2024
FY2023 Aug 31, 2022 $2.06B Nov 8, 2023
FY2022 Aug 31, 2021 $1.71B Nov 2, 2022
FY2021 Aug 31, 2020 $1.62B Nov 4, 2021
FY2020 Aug 31, 2019 $1.58B Nov 5, 2020
FY2019 Aug 31, 2018 $1.48B Nov 6, 2019
FY2018 May 31, 2018 $1.56B Dec 3, 2018
FY2018 Feb 28, 2018 $1.45B Dec 3, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $327.83M Nov 5, 2025
FY2025 Aug 31, 2024 $794.87M Nov 5, 2025
FY2025 Aug 31, 2023 $1.77B Nov 5, 2025
FY2024 Aug 31, 2022 $793.96M Nov 6, 2024
FY2023 Aug 31, 2021 $413.16M Nov 8, 2023
FY2022 Aug 31, 2020 $140.87M Nov 2, 2022
FY2021 Aug 31, 2019 $211.18M Nov 4, 2021
FY2020 Aug 31, 2018 $450.62M Nov 5, 2020
FY2018 May 31, 2018 $533.89M Dec 3, 2018
FY2018 Feb 28, 2018 $219.27M Dec 3, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Aug 31, 2025 $1.78B Nov 5, 2025
FY2024 Aug 31, 2024 $2.12B Nov 6, 2024
FY2024 Apr 18, 2024 $700.00M Nov 6, 2024
FY2023 Aug 31, 2023 $1.78B Nov 8, 2023
FY2022 Aug 31, 2022 $1.91B Nov 2, 2022
FY2021 Aug 31, 2021 $1.58B Nov 4, 2021
FY2020 Aug 31, 2020 $1.75B Nov 5, 2020
FY2019 Aug 31, 2019 $1.75B Nov 6, 2019
FY2018 Aug 31, 2018 $1.92B Dec 3, 2018
FY2017 Aug 31, 2017 $2.14B Nov 9, 2017